{
  "drug_name": "Scopolamine",
  "url": "https://wikem.org/wiki/Scopolamine",
  "scraped_at": "2026-01-10T08:01:54.405823",
  "sections": {
    "Administration": {
      "text": "Type:\nAnticholinergics\n,\nCycloplegic\nDosage Forms:\nRoutes of Administration: scopolamine- transdermal. Scopolamine hydrobromide- IV, oral, Ophthalmic\nCommon Trade Names:",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Anticholinergics",
          "url": "https://wikem.org/wiki/Anticholinergics"
        },
        {
          "text": "Cycloplegic",
          "url": "https://wikem.org/wiki/Cycloplegic"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "0.32-0.1mg IV/IM/SubQ\n0.4-0.8mg PO\n1-2 drops (0.25% ophthalmic solution) up to 4 times daily\n1 transdermal patch q72h (each 1.5mg patch delivers 1mg scopolamine over 72h)",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "Sedation:\n6mo-3y: 0.1-0.15 mg IM/IV/subQ\n3-6y: 0.2-0.3 mg IM/IV/subQ\nVomiting: 6 mcg/kg subQ\nTransdermal patch not FDA-approved for children",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C\nLactation risk: infant risk is minimal\nRenal dosing: contraindicated in renal impairment\nHepatic dosing: contraindicated in hepatic impairment",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_pregnancy_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nGlaucoma\nChronic lung disease (repeated doses)\nProstatic hypertrophy\nPyloric obstruction",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Tachyarrhythmia\nHallucinations, confusion\nGlaucoma\nSystemic absorption of ophthalmic formulation",
          "tables": []
        },
        "Common": {
          "text": "Dry skin, diminished sweating\nXerostomia\nAmnesia, somnolence\nMydriasis, blurred vision\nLocal irritation",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "Tachyarrhythmia\nHallucinations, confusion\nGlaucoma\nSystemic absorption of ophthalmic formulation",
      "subsections": {
        "Common": {
          "text": "Dry skin, diminished sweating\nXerostomia\nAmnesia, somnolence\nMydriasis, blurred vision\nLocal irritation",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Dry skin, diminished sweating\nXerostomia\nAmnesia, somnolence\nMydriasis, blurred vision\nLocal irritation",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 9.5h (transdermal)\nMetabolism:\nExcretion:",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Belladonna alkaloid with anticholinergic (predominantly antimuscarinic) properties",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Anticholinergic toxicity",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Anticholinergic toxicity",
          "url": "https://wikem.org/wiki/Anticholinergic_toxicity"
        }
      ]
    }
  }
}